Nuestro Equipo
Ofreciendo una sólida base a través del liderazgo de PRCCI.
Junta de Directores
Kenneth S. Ramos, MD, PhD
Chairman of the Board
Kenneth S. Ramos, M.D., PhD, PharmB
Kenneth S. Ramos, MD, PhD, PharmB, is associate vice president for precision health sciences at the University of Arizona Health Sciences (UAHS), where he is responsible for developing precision-health strategies and approaches to health outcomes and health-care delivery.
Dr. Ramos provides senior leadership in the development of personal diagnostics and therapeutics for complex diseases, including cancer, cardiopulmonary disorders and diabetes. He works in collaboration with the deans of the five UAHS colleges, clinical department heads, institute and center directors, Banner – University Medicine, and external stakeholders to develop and implement novel, high-impact programs and initiatives in precision health.
He is also a professor of medicine, at the UA College of Medicine – Tucson in the Department of Medicine, Division of Pulmonary, Sleep and Critical Care Medicine, where he directs his highly competitive and innovative research program in translational and clinical genetics and genomics and collaborates with numerous research groups across the UA campus.
Prior to his appointment, Dr. Ramos was with the University of Louisville Health Sciences Center, where he served as distinguished scholar and professor in the Department of Biochemistry and Molecular Biology. He was director of the Center for Genetics and Molecular Medicine and the Center for Environmental Genomics and Integrative Biology (a National Institute of Environmental Health Sciences core center), and chief scientific adviser for the Clinical Trials Laboratory. He was affiliated with the J.G. Brown Cancer Center, Birth Defects Center, Gheens Center for the Study of Aging, Center for Regulatory and Environmental Analytical Metabolomics, and Bioinformatics Initiative.
Dr. Ramos has also held faculty positions at Texas A&M University, where he held the Chester J. Reed Endowed Chair in Molecular Toxicology and oversaw the Department of Environmental and Occupational Health Sciences, School of Public Rural Health; Texas Tech University Health Sciences Center, Drexel University and the University of the Sciences in Philadelphia.
He has received more than $50 million in research funding, including R01, P01 and P30 grants, and has made seminal contributions in the areas of molecular toxicology, environmental health sciences, toxicogenomic and molecular medicine. As a senior scientist, he has been responsible for leading diverse research teams, conducting independent and collaborative research in biochemistry; bioinformatics; cell, computational, developmental, in vitro, molecular and theoretical biology; chemistry; environmental health; epigenetics; experimental therapeutics; genomics; nephrology; neurobiology; nutrition; oncology; pathology; pharmacology; physiology; public health and teratology. He has provided senior leadership in scientific and strategic research planning at the local, regional, national and international levels.
Dr. Ramos is recognized as a leading expert in the study of gene-gene and gene-environment interactions and genomic medicine. His research program integrates diverse approaches, ranging from molecular genetics to population-based public health studies in efforts to understand the genetic and genomic basis of human disease and to advance the goals of precision medicine. Ongoing basic science studies in his laboratory focus on repetitive genetic elements in the mammalian genome and their role in genome plasticity and disease, while his clinical work focuses on the characterization of diagnostic and prognostic biomarkers for chronic disease and cancer.
Gualberto (Gil) Medina, Esq., CPA
Treasurer of the Board
Gualberto (Gil) Medina
Gualberto (Gil) Medina joined the United States Commercial Real Estate Services (CBRE) in June 2013 as an Executive Vice President. Gil provides and coordinates integrated real estate solutions for corporate, governmental, non-profit and academic organizations. He is responsible for local and global business development across all CBRE service lines including: Office, Industrial, and Retail Brokerage; Asset Services; Project Management; and Financial Consulting. As part of developing and expanding major account service offerings, Gil provides corporate occupiers with multi-disciplined, high level strategic advisory expertise. In addition, Gil is involved with multiple strategic initiatives focused on business development and industry advancements.
Former, New Jersey state commerce secretary, Gil was the point-person in the creation of incentive, finance and regulatory programs that constitute the state’s core economic growth policies. He remains a key voice in the New Jersey commercial real estate industry, the larger business community, and public-private sector efforts that are guiding the state’s future economic health. In his professional career in both the public and private sectors, Gil negotiated over $5 Billion in incentives. Gil is an attorney, CPA and licensed real estate broker who has extensive expertise in management, sales, business development, technology, and regulatory matters. He serves as an advisor on economic growth policy to government officials in various states and large metropolitan centers.
Previous Positions:
- Executive Managing Director Cushman & Wakefield, Inc. (Managed firm’s New Jersey offices).
- Secretary of Commerce for the State of New Jersey
- President/General Counsel, start-up Biotechnology company (Arcanum Discovery, Inc.)
- Vice President of International Marketing, VOIP Firm (Net2Phone, Inc.)
- Manager at two Regional CPA Firms in Philadelphia
- Sole law practitioner
- Litigation Attorney – U.S. Department of Housing and Urban Development
Professional Recognition and Achievements:
- The President of Brazil conferred the Rank of Commander in the Order of Cruzeiro do Sul. This is the highest honor bestowed on foreign nationals by the Republic of Brazil, in recognition of valuable services rendered to the Republic and its citizens
- Informal Experts Group on IP Telephony of the International Telecommunication Union’s World Policy Forum on IP Telephony
- Served as a resource person for the ITU, the Federal Communications Commission and the US Department of State on telecommunications policy
- New Jersey Biotechnology Industry Organization Distinguished Service Award
- The US Biotechnology Industry Organization State Executive of the Year
- National Association of Industrial and Commercial Properties Industry Service Award
- City Councilman in the City of Camden, New Jersey
- Inducted into the New Jersey Business Hall of Fame
Boards, Organizations and Public Policy:
- Chairman of the Board of Solix Corporation, a process outsourcing firm that employs 1000 people throughout the U.S.
- New Jersey’s National Association of Industrial and Office Properties (NAIOP) – BoD. Served as VP Associate Affairs
- New Jersey Chamber of Commerce – Executive Committee
- Rutgers University School of Business – Advisory Board
- Rutgers University School of Business Real Estate Center – Executive Committee
- Rutgers University – Edward J. Bloustein School of Planning and Public Policy – Chairman of the Dean’s Leadership Council
- Board of Trustees – Thomas Edison State College – Served a two year term as Chairman of the Board of Trustees
- Board of Trustees & Vice Chairman – Puerto Rico Science Technology & Research Trust
- Board of Trustees – Caucus Education Corporation, Puerto Rico Consortium for Clinical Investigation
Donald H. Sebastian, PhD
Board Director
Dr. Donald H. Sebastian
Donald H. Sebastian is the Senior Vice President for Research & Development at New Jersey Institute of Technology. He is responsible for academic affairs across all six colleges as well the academic research enterprise, developing partnerships with industry and managing governmental affairs, intellectual property development, business incubation, commercialization, and contract projects across the technology spectrum. Under his leadership, the university’s sponsored research grew to over $90M in 2008, placing NJIT in the top 10 engineering universities in the nation, while Federal funding doubled over the last seven years. In 2006 he was inducted into the New Jersey High-Tech Hall of Fame.
Dr. Sebastian is the academic lead developing the Newark Institute for Regenerative Medicine that has been awarded a state grant of $50M to build and equip a 100,000 square foot facility connecting clinical practice using adult stem cell therapies back to basic research in close collaboration with industrial partners. The facility is a key element of the economic development plans for the University Heights district of Newark. The biotech focus complements economic development stemming from the Port Newark expansion – a project that benefits from NJIT-led assistance resulting in a $100M USDOT appropriation to the state of New Jersey (NJ) for Liberty Corridor development and designation as a corridor of national significance.
He has been the institutional lead in a State program to develop child-safe weapons technology that has drawn international media coverage, and attracted over $4M in state and federal support to develop the first biometric-based safety system for handguns. Dr. Sebastian was the principal academic organizer of the New Jersey Nanotechnology Consortium, bringing the resources of the Lucent Bell Labs Silicon Fabrication Research lab and e-Beam nano-facility to the statewide research community. He served as the first Chairman of the Board.
Currently, Dr. Sebastian is professor in the Department of Chemical, Biological and Pharmaceutical Engineering. He joined NJIT in 1995 and was later appointed executive director of the Center for Manufacturing Systems. In 1996, Dr. Sebastian was the founder of the NJ Manufacturing Extension Program, Inc., New Jersey’s operation under the National Institute of Standards & Technology (NIST)-sponsored, statewide assistance program for small to mid-sized manufacturers that has leveraged over $15M in federal funding. He continues as a member of the corporation’s Board of Directors.
Graduating as valedictorian of the class of 1974, he received his Bachelor of Engineering at Stevens, followed by a Masters of Engineering in 1975, and the Ph.D. in Chemical Engineering in 1977.
Carmen D. Zorrilla, MD
Board Director
Carmen D. Zorrilla, MD
Carmen D. Zorrilla, MD Professor of Obstetrics and Gynecology at the University of Puerto Rico School of Medicine, Medical Sciences Campus (MSC), and Interim Dean of Research at the UPR-MSC. She is certified by the American Board of Obstetrics and Gynecology and the American Academy of HIV Medicine. With experience in Ob-Gyn, HIV and COVID-19 related research that includes behavioral interventions and clinical trials with HIV infected and at-risk populations, as well as with pregnant and non-pregnant women. She was part of the group of examiners for the American Oral Board of Ob-Gyn (ABOG) for 22 years. She established an infrastructure for the care of pregnant and nonpregnant women living with HIV and leader in the successful efforts to eliminate the perinatal transmission of HIV in Puerto Rico. With zero transmission for the past 2 decades at her clinic, she also served as PI for the Integrated UPR Clinical Trials Unit (IUPR-CTU), and the UPR Mentoring Institute for HIV and Mental Health sponsored by NIAID and NIMH. A former member of the NIH Disparities and Minority Health Advisory Council (NACMHD) for the past 4 years, she has been a consultant for diverse national and international organizations including the National Institutes of Health (NIH), the Maternal and Child Health Bureau (MCHB), the Centers for Disease Control (CDC), the Agency for Health Research Quality (AHRQ), the National Academy of Science, Engineering and Medicine (NASEM) and others, and a former member of the Office of Women’s Health Advisory Committee and the CDC/HRSA AIDS and STD Advisory Committee (CHAC). Dr. Zorrilla has received multiple distinctions: PR Senate resolution and Distinction (1990), UPR President’s Recognition (2000), the “Bajari Award” by the PR Science, Technology and Research Trust for leadership in science and academia; a PR Senate Resolution and Diploma for contributions to eliminate HIV perinatal transmission and the APPIA-association of people living and affected by HIV-recognition of research and services on behalf of women living with HIV.
Dr. Zorrilla established the first group prenatal care program in PR (Centering Pregnancy) with funds from the Innovation Center of the Centers for Medicare & Medicaid Services (CMS), the first Spanish Centering Program outside of the mainland USA. The program had a reduction in preterm births and low birth weight among infants born of women enrolled in group prenatal care. Expanding the program to improve the health of mothers and infants is one of her professional goals. She established a multidisciplinary clinic for pregnant women with Zika in 2016 and implemented the Zika in Infants and Pregnancy (ZIP Study) in San Juan.
During the COVID-19 pandemic she spearheaded the development of a Molecular testing program at the RCM, a Phase III vaccine trial and a COVID Vaccine Center with a 97% vaccination rate of the faculty, students, and staff at the UPR-MSC. She is a member of the Scientific Coalition named by PR Governor Hon. Pedro Pierluisi, to advise on issues related to the COVID pandemic response and to further incorporate the input of Science into public policy.
Eneida R. Nemecek, MD, MS, MBA
Board Director
Eneida R. Nemecek, MD, MS, MBA
Dr. Eneida Nemecek is a Professor of Pediatrics and Medical Oncology and Medical director of Clinical Research at the Knight Cancer Institute-Oregon Health & Science University (OHSU) in Portland, Oregon. Native from Puerto Rico, she completed her Pediatric residency at Case Western Reserve University in Cleveland, OH and Pediatric Hematology/Oncology fellowship at the Fred Hutchinson Cancer Research Center in Seattle, Washington. She has a Master in Epidemiology and Clinical Research from the University of Washington and a Master in Healthcare Business Administration from OHSU. Dr. Nemecek is an established clinical researcher with over 20 years of experience in trials ranging from investigator-initiated early phase to large, multicenter studies funded by a variety of mechanisms. Her research focuses on bone marrow and cellular therapies, experimental oncology therapeutics and health services research addressing disparities in access for underrepresented groups. She has served in leadership roles in steering committees for several national cooperative research groups. She has also held elected leadership positions as director, trustee or committee chair in multiple professional organizations.
Wanda T. Maldonado-Dávila, BS Pharm, PharmD
Board Director
Wanda T. Maldonado-Dávila, BS Pharm, PharmD
Sten H. Vermund, MD, PhD
Board Director
Sten H. Vermund, MD, PhD
Sten H. Vermund, MD, PhD, is Dean of the University of South Florida College of Public Health in Tampa, serving as a Distinguished University Health Professor of Public Health and Pediatrics. In addition, he is Senior Associate Vice President in USF Health, Director of the Cancer Control Prevention and Epidemiology Program for Tampa General Hospital, and Chief Medical Officer of the Global Virus Network. He is a board-certified pediatrician and board-certified preventive medicine physician, trained at Babies Hospital/Columbia Presbyterian Medical Center in New York City. He has been engaged in infectious disease epidemiology research, application, and teaching for over 40 years. Dr. Vermund works in resource-limited settings on global virus control and maternal, infant, and child health, including HIV/AIDS, sexually transmitted infections, COVID-19, and parasitic diseases. He is active in global science education and in addressing vaccine hesitancy through microbiology education for lay audiences and policymakers. Dr. Vermund’s work in implementation science seeks to increase coverage and quality of infectious and chronic disease services. Current projects focus on maternal and child health capacity building in Chad, molecular phylogeny of HIV in Kazakhstan, and HIV prevention in the U.S. Past positions are at Yale (as Dean of the School of Public Health), Vanderbilt, UAB, NIH, Einstein, and Columbia. Dr. Vermund founded the Centre for Infectious Disease Research in Zambia (CIDRZ) and Friends in Global Health in Mozambique and Nigeria; all three non-governmental organizations are providing vital clinical care and research guidance in their home nations. He has communicated his work in over 750 peer reviewed articles, book chapters, and commentaries. Dr. Vermund is a member of the U.S. National Academy of Medicine, a Fellow of the American Association for the Advancement of Science and was President of the Connecticut Academy of Science and Engineering through 2024.
Líderes de PRCCI
Amarilys Silva-Boschetti,PharD
Executive Director
Dr. Amarilys Silva, Pharm. D
Doctor of Pharmacy (Pharm.D.) with diverse experience working in Healthcare and global exposure in the Pharmaceutical Industry in the areas of Research, Medical Affairs, Global Product Safety/Pharmacovigilance, Regulatory Affairs. Dr. Silva holds a Bachelor’s degree in Pharmaceutical Sciences from the University of Puerto Rico, School of Pharmacy, and a Doctor of Pharmacy degree from the University of Florida, Gainesville. Proficient in multiple Therapeutic Areas, Academic partnerships, Compliance, GxPs, Auditing (FDA, EMEA, etc.) along with strong managerial and clinical experience.
Dr. Silva is recognized as a leader in Clinical Research by the Puerto Rico medical community, Academia, government institutions, and pharmaceutical industry. She is also recognized as a partner of excellence and has developed relationships of mutual trust and respect with many internal and external stakeholders in US and Puerto Rico. Dr. Silva is passionate about diversity and inclusion. She is focused on innovation to help improve patient outcomes.
Wilfredo E. De Jesus-Monge, MD, MSc
Clinical Research Director
Wilfredo E. De Jesus-Monge, MD, MSc
He earned his MD in 2004 and an MSc in Clinical Research in 2007 from the University of Puerto Rico, followed by a Postdoctoral Research Fellowship at
UMass Medical School in 2012.
Dr. De Jesus-Monge has held nearly every role in site study operations, including Clinical Research Coordinator, Blinded rater, Chair, Director, Chief, Sub-Investigator, and Principal Investigator.
He is a respected academician, research mentor, and national-level speaker, and has received numerous awards. He was the 2023 Gold Clinical Researcher (Coordinator) of the Year awarded by PharmaTimes Magazine. His successful grant writing has secured competitive funding for prestigious organizations such as the American Cancer Society and St. Baldrick’s Foundation.
Nationally recognized for his innovative research, Dr. De Jesus-Monge served as a judge for the 2023 Fierce Innovation Awards and was a 2023 finalist at the WCG Innovation Challenge-East.
He presented at the 2023 Society for Clinical Research Sites’ Global Oncology Site Solutions Summit and was honored with the 2012 TEN Award for Innovative Research by Genetic Engineering and Biotechnology News at the BIO International Convention. He has also received training in clinical research innovation and entrepreneurship from the 2024 Bizy Academy (YEES! and University of Notre Dame) and the 2023 Fase1 Intensive (Puerto Rico Science, Technology, and Research Trust).
Currently, Dr. De Jesus-Monge is an Assistant Research Professor (ad honorem) at San Juan Bautista School of Medicine and serves as the Clinical Research Director at PRCCI, where he plays a pivotal role in developing the Clinical Research Center, mentoring staff, participating in projects, and contributing to the education and training of personnel and new investigators.
Ricardo García Toledo, CPA
Finance Lead
Ricardo Garcia Toledo, CPA
Ricardo Garcia Toledo, CPA –Finance Lead at PRCCI- career began on public accounting transitioning then to the manufacturing industry (medical devices, pharmaceutical and contract manufacturing) acquiring extensive experience supporting multiple sites and organizations. Ricardo completed a Bachelor’s Degree in Business Administration-Accounting from the University of PR-Bayamón and is also a Certified Public Accountant.
Former employers include; KPMG, Wyeth and Merck and also other organizations (construction, service, retail) as a consultant. Ricardo’s accomplishments include implementation of SAP, lean manufacturing processes, legal entity integrations, contracts re-negotiation, worldwide product cost standardization project, time and attendance systems and foreign trade zone implementation among others. Ricardo’s experience includes; financial planning (budgeting and forecasting), financial reporting, incremental costing analysis, financial analysis, inventory, compliance, taxes, payroll, collections, accounts payables and general accounting.
Jorge Martínez, MPH
Clinical Research Operations & Special Projects Lead
Jorge Martínez, MPH
Jorge Martínez is the Research Operations Lead for PRCCI. Jorge has a Bachelor’s Degree in General Science from the University of Puerto Rico, Rio Piedras Campus and a Master’s Degree in Public Health from the University of Puerto Rico, Medical Sciences Campus. Since college, he has always had a passion for science and health. After graduating from his Master’s Degree, he worked supporting the island’s Primary Health Centers in their educational programs. Jorge also took an introductory research program at the Veterans Affairs (VA) Caribbean Healthcare System in which he was coordinator for two studies in the area of Emergency Management. Martínez works directly with stakeholders, including Sponsors, Clinical Research Organizations, among others, to help the growth of clinical investigation in Puerto Rico.
Mitzy González, EdD
Training and HIPAA Compliance Officer
Mitzy González
During her over twelve years of experience as health professional she has specialized in addictive disorders and mental health. Mitzy has a passion for the well-being of patients, their privacy, healthy lifestyles and development of health prevention skills. Among other areas, Mitzy has actively collaborated with support groups on seminars addresing topics ranging from empowerment to leadership and prevention.
Edmagally Villafañe, RN, BSN
Clinical Research Regulatory Manager & CRC Training
Edmagally Villafañe, RN, BSN
Edmagally Villafañe, RN, BSN
Clinical Research Quality Manager
Teric Brito, JD
Clinical Research Legal & Compliance Advisor
Teric Brito, JD
Teric Brito, JD – Clinical Research Legal & Compliance Advisor
Equipo de PRCCI
El éxito de nuestro equipo se basa en la colaboración. Nuestro objetivo es establecer la diversidad en nuestras iniciativas de investigación y promover el bienestar de los pacientes. Juntos, nos esforzamos por ofrecer resultados excepcionales y brindar servicios excepcionales a nuestras partes interesadas.
Obed Pérez
Operations Coordinator
Obed Pérez
Obed Pérez is the Operations and Business Development Specialist for PRCCI. Obed obtained a Bachelor’s degree in Business Administration with a focus on Management from the University of Puerto Rico. He completed an internship program in the pharmaceutical industry where he obtained hands on experience on project management, process improvements, cost reductions, operational excellence, GMP regulations, supply chain management on warehouse & logistics, sourcing & procurement and planning functions. His major focus was on plant capacity production planning and performance metrics.
Juliemar Aponte, MS
Research Associate
All of Us Research Program
Juliemar Aponte, MS
Juliemar Aponte, MS
Research Associate All of Us Research Program
Francisco J. Alegría Tejeda
Financial Analyst
Francisco J. Alegría Tejeda
Francisco J. Alegría Tejeda serves as a Financial Analyst at the Puerto Rico Consortium for Clinical Investigation, where he specializes in leveraging QuickBooks and Excel for financial modeling, forecasting, and precise financial tracking. Francisco holds a Bachelor’s degree in Accountancy and Marketing Management from the University of Puerto Rico, Rio Piedras Campus. He has gained extensive experience in private credit lending, asset services, and audit engagements through internships at Popular Bank, Morgan Stanley, and Ernst & Young. His expertise includes financial reporting, risk assessment, and audit services. Francisco brings a data-driven approach to financial analysis and decision-making.
Ana Doris Gómez Granados
Quality & Patient Recruitment Specialist
Ana Doris Gómez Granados
Ana Doris came to PRCCI in 2020. She seeks to use her skills and experience for the advantage of clinical trials.
Her experience includes various health and sciences fields. Ana Doris studied Clinical Laboratory Sciences as well as a Diplomate in Environmental Microbiology at the University of Santander in Colombia. Following that, a few years later she received an MS in Biomedical Sciences at the Industrial University of Santander in Colombia. She served as a professor in Colombia where she mentored undergraduates and graduate students from research to experiments and general guidance of the fields. Coming to Puerto Rico, she became a Healthcare Service Representative, supporting health insurance holders.
Zuna Maza
Strategic Communications Consultant
Zuna Maza
Zuna joined the PRCCI team in 2019 as Strategic Communications Consultant reporting to Dr. Amarilys Silva. She provides internal and external strategic communications advice with the main focus on: communications platform design, institutional identity, and targeted communications programs for core publics among the clinical research ecosystem and the general public. Zuna obtained a Master’s degree in Public Relations from Boston University and a Bachelor’s in communications from the University of PR Communications School.
She has a solid track record directing institutional communications for worldwide pharmaceutical and banking corporations, managing local and international top public relations firms in the island and the academia acting as Coordinator and Professor for the University of the Sacred Heart Graduate Public Relations program, first to be established in the island. Also, she is skilled in Strategic Communications, Issue & Reputation Management, Advocacy & Coalition Building, Corporate Responsibility, and Media Relations initiatives. She is accredited by the Public Relations Society of America and licensed by the PR Public Relations Association (ARPPR, acronym in Spanish) and has received multiple recognitions by the ARPPR, trade associations, and news publications.
Marianne Vázquez
Clinical Research Coordinator
Estos individuos talentosos conforman la columna vertebral de nuestro equipo, trabajando armoniosamente juntos para lograr la excelencia en todo lo que hacemos. Conoce mejor a cada miembro del equipo y descubre cómo su experiencia y dedicación impulsan el éxito de nuestra organización.
